ABCC2 and clinical outcome of tamoxifen therapy.
Lang
Thomas
T
Schroth
Werner
W
Brauch
Hiltrud
H
Schwab
Matthias
M
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D017024:Chemotherapy, Adjuvant; D006801:Humans; D000089762:Multidrug Resistance-Associated Protein 2; D027425:ATP-Binding Cassette, Sub-Family C Proteins / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic; D013629:Tamoxifen
D018931:Antineoplastic Agents, Hormonal; D000089762:Multidrug Resistance-Associated Protein 2; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D013629:Tamoxifen; C000715087:ABCC2 protein, human